摘要
2018年10月17日,在加拿大境内大麻全面合法化,人们对大麻及其提取物的药用价值越来越重视。大麻二酚是从大麻中提取的非精神活性成分,不会导致生理依赖,具有良好的耐受性,对神经疾病、癫痫、肿瘤、炎症、肝损伤、糖尿病、疼痛等多种疾病都表现出一定的治疗特性,在医药领域的重要性越发凸显出来。该文就大麻二酚的药理研究展开综述,以期为大麻二酚治疗相关疾病和合理利用提供参考。
On October 17,2018,marijuana was fully legalized in Canada,and people paid more and more attention to the medicinal value of marijuana and its extract.Cannabinol is a non-psychoactive ingredient extracted from hemp,which does not lead to physiological dependence and has good tolerance.It has certain therapeutic characteristics for neurological diseases,epilepsy,tumors,inflammation,liver injury,diabetes,pain and other diseases.Its importance in the field of medicine has become more and more prominent.This article reviews the pharmacological studies of cannabinol,so as to provide references for the treatment of related diseases and rational utilization of cannabinol.
出处
《药物资讯》
2019年第3期49-55,共7页
Pharmacy Information
基金
辽宁省自然科学基金资助项目(材料联合基金)(项目编号:20180510016)。
